Trade RxSight, Inc. - RXST CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.31 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 51.79 |
| Open | 51.83 |
| 1-Year Change | 199.08% |
| Day's Range | 51.83 - 53.18 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | 51.79 | 0.56 | 1.09% | 51.23 | 52.00 | 50.21 |
| Apr 24, 2024 | 52.78 | -2.16 | -3.93% | 54.94 | 56.12 | 52.58 |
| Apr 23, 2024 | 54.63 | 2.00 | 3.80% | 52.63 | 55.07 | 52.16 |
| Apr 22, 2024 | 52.27 | 1.71 | 3.38% | 50.56 | 52.82 | 50.33 |
| Apr 19, 2024 | 51.40 | -0.20 | -0.39% | 51.60 | 52.55 | 50.10 |
| Apr 18, 2024 | 51.67 | -0.31 | -0.60% | 51.98 | 52.93 | 50.88 |
| Apr 17, 2024 | 52.60 | -0.84 | -1.57% | 53.44 | 54.36 | 52.18 |
| Apr 16, 2024 | 54.26 | 2.20 | 4.23% | 52.06 | 54.29 | 52.05 |
| Apr 15, 2024 | 53.19 | -1.74 | -3.17% | 54.93 | 57.08 | 52.21 |
| Apr 12, 2024 | 55.00 | 0.61 | 1.12% | 54.39 | 55.08 | 53.82 |
| Apr 11, 2024 | 55.13 | 2.20 | 4.16% | 52.93 | 55.28 | 52.65 |
| Apr 10, 2024 | 52.50 | -0.57 | -1.07% | 53.07 | 54.90 | 52.43 |
| Apr 9, 2024 | 54.99 | -1.33 | -2.36% | 56.32 | 56.49 | 54.59 |
| Apr 8, 2024 | 56.25 | 0.72 | 1.30% | 55.53 | 56.71 | 53.59 |
| Apr 5, 2024 | 55.00 | 4.07 | 7.99% | 50.93 | 56.44 | 50.93 |
| Apr 4, 2024 | 51.93 | 0.09 | 0.17% | 51.84 | 53.21 | 51.27 |
| Apr 3, 2024 | 51.16 | 1.60 | 3.23% | 49.56 | 51.62 | 49.13 |
| Apr 2, 2024 | 50.30 | 1.36 | 2.78% | 48.94 | 50.45 | 48.44 |
| Apr 1, 2024 | 50.43 | -0.20 | -0.40% | 50.63 | 50.63 | 49.17 |
| Mar 28, 2024 | 51.45 | 0.77 | 1.52% | 50.68 | 51.91 | 49.70 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
RxSight, Inc. Company profile
About Rxsight Inc
RxSight, Inc. is a commercial-stage medical technology company. The Company is engaged in improving the vision of patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system), comprised of its RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Its LAL is made of photosensitive material that changes shape in response to patterns of ultraviolet (UV) light generated by its LDD. Its RxSight system helps surgeon to performs a standard cataract procedure to implant the LAL, and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes. Alternative IOL technologies, are not adjustable following the surgery and therefore require patients to make pre-operative choices about their visual preferences.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Rxsight Inc revenues increased 54% to $22.6M. Net loss applicable to common stockholders totaled $48.7M vs. income of $3.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Change in fair value of warrants decrease of 96% to $2.7M (income), Selling, general and administrative - B increase from $15.1M to $31.2M
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Columbia Street
Suite 120
ALISO VIEJO
CALIFORNIA 92656
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com